Skip to content

Dapoxetine

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: dapoxetine hydrochloride, LY-210448, priligy

ATC G04BX14

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Dapoxetine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including SLC6A4. Recorded indications include Premature ejaculation.

  • Molecular targets: SLC6A4 (1 listed in DrugCentral).
  • Indications: Premature ejaculation.
  • ATC code: G04BX14 (Other urologicals).
  • Molecular formula: C21H23NO; molecular weight 305.42 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Premature ejaculation

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Sodium-dependent serotonin transporterSLC6A4inhibitorIC50 8.95

ATC classification

ATC codeTherapeutic hierarchy
G04BX14GENITO URINARY SYSTEM AND SEX HORMONES › UROLOGICALS › UROLOGICALS › Other urologicals

Pharmacogenomics

Drug-label and guideline annotations from PharmGKB and CPIC.

  • Swissmedic label: CYP2D6 · Actionable PGx

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Sudden hearing loss36.5

Chemical structure

Molecular formulaC21H23NO
Molecular weight305.42 g/mol
CAS number119356-77-3
InChIKeyUSRHYDPUVLEVMC-FQEVSTJZSA-N
PubChem CID71353
CN(C)[C@@H](CCOC1=CC=CC2=C1C=CC=C2)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Dapoxetine used for?

DrugCentral lists the following indications for Dapoxetine: Premature ejaculation.

How does Dapoxetine work?

Its molecular targets in DrugCentral include SLC6A4 (inhibitor).

What is the chemical formula of Dapoxetine?

Dapoxetine has the molecular formula C21H23NO and a molecular weight of 305.42 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC21H23NO
DrugCentral ID4381
Interactive profile